UNCY

Unicycive Therapeutics (UNCY)

About Unicycive Therapeutics (UNCY)

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Details

Daily high
$6.78
Daily low
$6.32
Price at open
$6.32
52 Week High
$11.00
52 Week Low
$3.71
Market cap
133.0M
Dividend yield
0.00%
Volume
599,173
Avg. volume
715,681
P/E ratio
-1.90

Unicycive Therapeutics News

Details

Daily high
$6.78
Daily low
$6.32
Price at open
$6.32
52 Week High
$11.00
52 Week Low
$3.71
Market cap
133.0M
Dividend yield
0.00%
Volume
599,173
Avg. volume
715,681
P/E ratio
-1.90